CONTACT |
LinkedIn
Cergentis

Cergentis' Targeted Locus Amplification (TLA) Technology uniquely enables the targeted complete Next Generation Sequencing of any genomic locus in any genome of interest.

 

TLA uses the physical proximity of nucleotides within a locus of interest as the basis of selection and requires just one primer pair complementary to a short locus-specific sequence to amplify 10.000's of basepairs of surrounding sequence information.

TLA-based sequencing results in complete sequence information and the detection of all Single Nucleotide Variants & Structural Variants. In combination with short and long read NGS Sequencing, TLA also enables haplotyping.

 

Cergentis provides kits and services.